Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,224,395
-
Total 13F shares
-
36,917,618
-
Share change
-
+7,359,799
-
Total reported value
-
$3,014,269,128
-
Put/Call ratio
-
203%
-
Price per share
-
$81.64
-
Number of holders
-
152
-
Value change
-
+$632,622,766
-
Number of buys
-
115
-
Number of sells
-
15
Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q4 2020
As of 31 Dec 2020 Beam Therapeutics Inc. - COMMON STOCK (BEAM) had 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,917,618 shares of stock of the company.
Largest 10 holders included FMR LLC, Redmile Group, LLC, Temasek Holdings (Private) Ltd, BlackRock Inc., HILLHOUSE CAPITAL ADVISORS, LTD., VANGUARD GROUP INC, STATE STREET CORP, ARK Investment Management LLC, SC CHINA HOLDING Ltd, and Cormorant Asset Management, LP.
This table shows 152 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.